Terminated NA INTERVENTIONAL 1-arm NCT04934397

Term Infants Fed a Partially Hydrolyzed Whey Protein-Based Formula

Tolerance in Term Infants Fed a Partially Hydrolyzed Whey Protein-Based Formula With Oligosaccharides

Sponsor: Abbott Nutrition

Updated 5 times since 2021 Last updated: Jun 8, 2022 Started: Jul 8, 2021 Primary completion: Feb 18, 2022 Completion: Feb 18, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Product Availability Due to Recall

Other terminated trials from Abbott Nutrition

See all terminations from Abbott Nutrition

This NA trial investigates Gastro-Intestinal Tolerance and is currently terminated or withdrawn. Abbott Nutrition leads this study, which shows 5 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jul 2022 — Jul 2024 [monthly]

Terminated NA

Status: Recruiting → Terminated
Oct 2021 — Jul 2022 [monthly]

Recruiting NA
Sep 2021 — Oct 2021 [monthly]

Recruiting NA

First recorded

Jul 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Abbott Nutrition

Data source: Abbott Nutrition

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Charleston, United States , Columbus, United States , Covington, United States , Dayton, United States , Dothan, United States , Idaho Falls, United States , Lincoln, United States , Longview, United States , Memphis, United States , Mentor, United States and 2 more locations